Since both MCH and its receptors were found to be upregulated in the intestine of patients with inflammatory bowel disease and of mice with TNBS-induced colitis [12], we subsequently examined mRNA levels of MCHR1b and MCHR2 in brain vs. gut and in response to TNBS treatment. This evidence concerns the gene MCHR2 and colitis.